A new Oxford study will deliberately reinfect recovered COVID-19 patients
Researchers at the University of Oxford are looking for 64 healthy people between the ages of 18 and 30 who have recovered from COVID-19. In a new, first-of-its kind study, the volunteers will be reinfected with the original strain of the coronavirus first identified in Wuhan, China, under controlled, quarantined conditions for 17 days, the university said Monday.
The main goal of the challenge trial is to discover what levels and types of immunity are needed to prevent reinfection, which could aid vaccine developers going forward. So far, natural infections and vaccines appear to provide strong protection against reinfection for the most part, but it's unclear how long that will last. The study may also reveal how much virus it takes to reinfect a recovered patient.
While Oxford is excited about the study's potential, challenge trials have their critics, who argue that deliberately infecting someone is unethical, regardless of the circumstances. Read more at Bloomberg.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Swiss bliss: Chenot Palace Weggis takes wellness to the next level
The Blend Heath retreat on Switzerland's Lake Lucerne offers a mid-winter reset
By Felix Bischof Published
-
Earth's mini-moon was the moon all along
Under the radar More lunar rocks are likely floating in space
By Devika Rao, The Week US Published
-
Crossword: February 4, 2025
The Week's daily crossword
By The Week Staff Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published